Molly Suggs

680 Articles Published | Follow:
New Orleans Hosts Psychedelic Research Conference Double-Header
Turning On The Culture
New Federal Bill Aims to Establish VA Office of Novel Therapeutics
Federal Support for U.S. Psychedelic Research Accelerates 5-MeO-DMT Clinical Trials
Beyond FDA Approval: Psychedelics as Catalysts For Creativity and Innovation 
Authors of Largest Microdosing Study Suggest Benefits Limited To Dosing Day
New RAND Report Shows Therapeutic Use Driving U.S. Views Towards Psychedelics
Oregon’s Psilocybin Program: Industry Insiders Weigh In On Closures and the Future
Varying Approaches to Psychedelic Policy Reform in Washington State
Legislation, Industry, and the Future of Psilocybin for PTSD